FOLH1 and prostate cancer: Due to the high sensitivity (pooled 71–80%) and specificity (pooled 95–99%), Morigi et al. emphasize the high value of PSMA-PET/CT for the initial staging of high-risk prostate cancer in their non-systematic meta-analysis [26].